Business Affairs

RedHill Biopharma And Gaelan Medical Enter Into License Agreement For Talicia® For The United Arab Emirates

Comment(0)
Published by
The Street

By PR Newswire RALEIGH, N.C. and TEL-AVIV, Israel, Jan. 6, 2022 /PRNewswire/ — RedHill Biopharma Ltd. (Nasdaq: RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company, announced that it has entered into an exclusive license agreement with Gaelan Medical Trade LLC (“Gaelan Medical”), a wholly owned subsidiary of the Ghassan Aboud Group (GAG), for Talicia® (omeprazole magnesium, amoxicillin and rifabutin) [1], an H. pylori therapy, in the United Arab Emirates (UAE). Under the terms of the agreement, RedHill will receive an upfront payment of $2 million and is eligible for add…

Read More

Related Articles
Business Affairs

Gulf Air concludes Dubai Airshow participation with great achievements

Qatar Newswire

Manama, Gulf Air, the national carrier of the Kingdom of Bahrain, concluded its participation in Dubai Airshow 2021 with great achievements as it signed a number of agreements during the event and used it as a platform to promote its fleet, products an…
Business Affairs

QIB Recognized for Its Outstanding Innovations at the Global Finance 2021 Innovators Awards

Qatar Newswire

Qatar Islamic Bank (QIB) was again crowned for revolutionizing the banking sector in Qatar and the global Islamic Banking industry with the introduction of innovative digital banking solutions for both retail and corporate customers. The Bank was award…
Business Affairs

QFCRA Bolsters its Partnership with Microsoft

Qatar Newswire

The Qatar Financial Centre Regulatory Authority (QFCRA) has bolstered its partnership with Microsoft Company by signing a memorandum of understanding (MoU). This aims to use the company’s advanced cloud-computing services, improve operational performan…

Leave a Reply

Your email address will not be published. Required fields are marked *